Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats

Atherosclerosis

Volumn 149, Issue 2, 2000, Pages 315-322

  Proctor, S D ^a   Pabla, C K ^b   Mamo, J C L ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Atherosclerosis; Chylomicrons; Diabetes; LDL; Retention

Indexed keywords

CHYLOMICRON; LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BIOACCUMULATION; CONTROLLED STUDY; DIABETES MELLITUS; INSULIN DEFICIENCY; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

ANIMALS; ARTERIOSCLEROSIS; CHYLOMICRONS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; INSULIN; LIPOPROTEINS, LDL; MALE; RABBITS; RATS; RATS, WISTAR; REFERENCE VALUES; STREPTOZOCIN; TUNICA INTIMA;

EID: 0034060197     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00341-X     Document Type: Article

References (27)

1. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors and 12 yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444.
2. Navab M., Fogelman A.M., Berliner J.A., Territo M.C., Demer L.L., Frank J.S., Watson A.D., Edwards P.A., Lusis A.J. Pathogenesis of atherosclerosis. Am. J. Cardiol. 76(9):1995;C18-C23. Special Issue.
3. Deman F.H.A.F., Cabezas M.C., Vanbarlingen H.H.J.J., Erkelens D.W., Debruin T.W.A. Triglyceride-rich lipoproteins in non-insulin dependent diabetes mellitus - postprandial metabolism and relation to premature atherosclerosis. Eur. J. Clin. Invest. 26(2):1996;89-108.
4. Syvanne M., Rosseneu M., Labeur C., Hilden H., Taskinen M.R. Enrichment with apolipoprotein E charaterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease - a preliminary report. Atherosclerosis. 105(1):1994;25-34.
5. Bowler A., Regrave T.G., Mamo J.C.L. Chylomicron remnant clearance in homozygote and heterozygote wanatabe heritable hyperlipiemic rabbits is defective: lack of evidence for an independent chylomicron remnant receptor. Biochem. J. 276:1991;381-386.
6. Nordestgaard B.G., Tybjderg-Hansen A. IDL, VLDL, chylomicrons and atherosclerosis. Eur. J. Epidemiol. 8:1992;92-98.
7. Proctor S.D., Mamo J.C.L. Arterial fatty lesions have increased uptake of chylomicron remnants but not low density lipoproteins. Coron. Artery Dis. 7:1996;239-245.
8. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 276(11):1986;875-881.
9. Hamilton C.A. Low density lipoprotein and oxidised low density lipoprotein - their role in the development of atherosclerosis. Pharmacol. Ther. 74(1):1997;55-72.
10. Mamo J.C.L., Wheeler J.R. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as smaller macromolecules including low density lipoprotein, high density lipoprotein and albumin. Coron. Artery Dis. 5:1994;695-705.
11. Proctor S.D., Mamo J.C.L. Retention of fluorescence-labelled chylomicron remnants within the intima of the arterial wall. Eur. J. Clin. Invest. 28:1998;497-503.
12. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
13. Pittman R.C., Carew T.E., Glass C.E., Green S.R., Taylor C.A. Jr, Attie A.D. A radioiodinated, intracellular trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem. J. 212:1983;791-800.
14. Medina R., Cardonasanclemente L.E., Born G.V.R., Brown M.J. Effect of captopril and losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats. J. Cardiovasc. Pharmacol. 29(1):1997;125-129.
15. Fidge N.H., Poulis P. Studies on the radioiodination of very low density lipoprotein from different mammalian species. Clin. Chim. Acta. 52:1974;15-26.
16. Egusa G., Brady D.W., Grundy S.M., Howard B.V. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein apolipoprotein B. J. Lipid Res. 24:1983;1261-1267.
17. Stender S., Zliversmit D.B. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits: molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis. 1:1981;38-49.
18. Nordestgaard B.G., Zilversmit D.B. Large lipoproteins are excluded from the arterial wall in diabetic cholesterol fed rabbits. J. Lipid Res. 29:1988;1491-1500.
19. Duff G.L., McMillan G.C. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. I. The inhibition of experimental cholesterol atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the regression of experimental cholesterol atherosclerosis. J. Exp. Med. 89:1949;611-630.
20. Simionescu N., Simionescu M. Cellular interactions of lipoproteins with vascular endothelium, endocytosis and transcytosis. Targital. Diagn. Ther. 5:1991;45-95.
21. Bucala R., Makita Z., Vega G., Grundy S., Koschinsky T., Cerami A., Vlassara H. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA. 91(20):1994;9441-9445.
22. Chang M.Y., Olin K.L., Tsoi C., Wight T.N., Chait A. Human monocyte derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins. J. Biol. Chem. 273(26):1998;15985-15992.
23. O'Brien K.D., Olin K.L., Alpers C.E., Chiu W.B.A., Ferguson M.B.S., Hudkins K.M.S., Wight T.N., Chait A. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: co-localization of biglycan with apolipoproteins. Circulation. 98(6):1998;519-527.
24. Stewart M.W., Humphriss D.B., Mitcheson J., Webster J., Walker M., Laker M.F. Lipoprotein composition and serum apolipoproteins in normoglycaemic first degree relatives of non-insulin dependent diabetic patients. Atherosclerosis. 139(1):1998;115-121.
25. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors and 12yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444.
26. Steiner G. Diabetes and atherosclerosis: epidemiology and intervention trials. Woodford F.P., Davignon J., Sniderman A. Atherosclerosis. X:1995;749-752 Elsevier Science, city.
27. Steiner G. The Diabetes Atherosclerosis Intervention Study (DAIS). Jacotot B., Mathe D., Fruchart J.-C. Atherosclerosis. XI:1998;267-271 Elsevier Science, city.